TREAT-AD: TaRget Enablement to Accelerate Therapy Development for AD

There is a newer version of the record available.

Published August 16, 2022 | Version v1
Report Open

IUSM-Purdue TREAT-AD Center Target Enabling Component PLCγ2 In Vitro Micelle Assay Using the Hydrophobic C16CF3-coumarin Substrate

Description

A Target Enabling Component describing the Micelle Assay for PLCG2

Files

PLCG2 micelle assay TEP Component Introduction Only.pdf

Files (175.3 kB)

Name Size
md5:542e0c90ead7ee017405249cad73eade
175.3 kB Preview Download